Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
Date:6/30/2008

rently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2007 and the quarterly report on Form 10-Q for the quarter ended January 31, 2008. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Contacts:

GendeLLindheim BioCom Partners

Investors Media

info@peregrineinc.com Jennifer Anderson

(800) 987-8256 (212) 918-4642


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
2. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
3. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
4. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
5. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
6. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
7. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
8. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
11. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... CITY, Calif. , May 21, 2015  Cardica, Inc. ... 2015, new employee Greg Watson , the company,s vice ... shares of the company,s common stock, at a per share ... 20, 2015. The stock option was granted pursuant to Cardica, ... of directors in May 2015 under Rule 5653(c)(4) of the ...
(Date:5/21/2015)... , May 21, 2015 /PRNewswire/ ... von Arzneimittelfälschungen - Zwecks Leistungsvergleich zur ... wird auf EG-Mitgliedstaaten verwiesen, in denen ... werden.  Wählen Sie ein Aegate-Land: beispielsweise ... Richtlinie zur Bekämpfung von Arzneimittelfälschungen (FMD) ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 Research ... announced the addition of the "Global Next ... offering. The global next generation sequencing ... over the period 2014-2019 This report ... of the global next generation sequencing market for ...
Breaking Medicine Technology:Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3Global Next Generation Sequencing Market 2015-2019 2
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President and ... by Consulting-Specifying Engineer (CSE) magazine as a young leader ... the May/June issue of the publication. , This award ... and younger who have, and continue to make significant ... other areas of their professional and personal endeavors. Candidates ...
(Date:5/22/2015)... Anaheim, Calif. (PRWEB) May 22, 2015 ... newly opened Anaheim Fit Body Boot Camp, recently accepted ... milestone so quickly after the launch of his location ... upon the Anaheim community. , Fit Body Boot Camp ... fitness boot camp franchise with hundreds of locations across ...
(Date:5/22/2015)... 2015 Javon Bea Mercy Health ... for providing the highest quality emergency care services, especially ... decision-making,” said Javon R. Bea, President and CEO of ... our employee/partners to care for and respond to what ... not apply for this award, but are selected if ...
(Date:5/21/2015)... Her popular Love Seminar will be coming to ... Gabriel on Saturday, May 23rd. , A statement that ... women who are unhappy in their relationships has been, "If ... think that their biggest problem is not being able to ... relationship to another trying to find the right person. The ...
(Date:5/21/2015)... Ticket Down is a reliable source for authentic ... Guatemala on Friday, July 3rd at LP Field in Nashville, ... fan of international soccer. The number of chances to watch some ... is growing at a large clip. Over the past several years, ... USA to play in front of the American people. The match ...
Breaking Medicine News(10 mins):Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2
... midlife may flood brain with toxic substances, researcher says , , ... age more than triples the risk of senility decades later, ... between obesity and dementia. , "The take-home message is that ... carry your weight in midlife," said study author Rachel Whitmer, ...
... PHILADELPHIA, March 26 Researchers at The,Children,s Hospital ... today by the New Jersey Teen Driver,Study Commission. ... reduce the number one killer of teens: motor ... right in line with the most,current research in ...
... serious troubles later on, study suggests , , WEDNESDAY, March ... may be linked to a softening of bones in ... found that breast-feeding without vitamin D supplementation could prolong ... serious health problems later in life, including decreased bone ...
... to be the largest study of its kind for the ... to Crohns Disease as well as further evidence that some ... , The study examined changes in DNA associated with the ... Disease (CD), which is most frequently marked by inflammation of ...
... 26 BD (Becton,Dickinson and Company) (NYSE: BDX ... of its second fiscal quarter 2008 earnings conference call ... will issue a press release,detailing the quarter,s earnings earlier ... will be accessible through BD,s,website at http://www.bd.com/investors ...
... of pediatric liver transplant recipients report lower health-related ... after the surgery, compared to reports from the ... dysfunction fall within the normal range. These findings ... Transplantation. The article is also available online at ...
Cached Medicine News:Health News:Abdominal Fat Boosts Dementia Risk 2Health News:Abdominal Fat Boosts Dementia Risk 3Health News:Teen Driving Experts at The Children's Hospital of Philadelphia Support New Recommendations From the New Jersey Teen Driver Study Commission 2Health News:Teen Driving Experts at The Children's Hospital of Philadelphia Support New Recommendations From the New Jersey Teen Driver Study Commission 3Health News:Too Little Vitamin D May Soften Baby's Skull 2Health News:Large multicenter study suggests new genetic markers for Crohn's disease 2Health News:Study shows lifetime effects of pediatric liver transplants 2
... HemoCue Hemoglobin Test ... and reliable quantitative hemoglobin ... performance as a large ... system consists of either ...
... product available for the Clinitek® 50 ... Strips provide albumin, creatinine and albumin-to-creatinine ... Clinitek® Microalbumin product is useful to ... diabetes or hypertension in order to ...
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
Medicine Products: